
doi: 10.1093/nass/nrm102
pmid: 18029657
Recently we found that an antisense 2'-O-methyloligonucleotide, with two terpyridine*Cu(II) complexes at contiguous internal sites, was highly active as a site-specific (sequence-specific) artificial ribonuclease, with the activity derived from the cooperative action of the complexes. Two kinds of terpyridine-linked nucleosides were used for the construction of the RNA cleaver, including a uridine derivative with terpyridine attached to the 2'-oxygen via a short linker arm. In order to explore more efficient cleavers (practical cleavers), we have constructed a structurally similar cleaver (18-mer), but containing a novel 2'-carbon-branched uridine with a terpyridine group instead of the aforementioned 2'-oxygen-modified uridine. The reaction of a 10-fold excess of the target RNA 24-mer with the new agent, in the presence of Cu(II) ions, and at pH 7.5 and 37 degrees C, revealed that the substrate was cleaved in 92% yield after 5 h. Under similar conditions, the previous cleaver was less active and the cleavage yield was 61%.
Organophosphorus Compounds, Ribonucleases, Oligonucleotides, Antisense, Uridine
Organophosphorus Compounds, Ribonucleases, Oligonucleotides, Antisense, Uridine
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 1 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
